AHA Coding Clinic® for HCPCS - 2008 Quarter 2; FOR your INFORMATION
Several HCPCS code changes for Medicare
Effective as of April 1, 2008, the following HCPCS codes are no longer payable to Medicare. HCPCS code Long descriptor J7602 Albuterol, all formulations including separated isomers, inhalation solution, FDA-approved final product, non-compounded, administered through DME, concentrated form, per 1 mg (Albuterol) or per 0.5 mg (Levalbuterol) J7603 Albuterol, all formulations including separated isomers, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose, per 1 mg (Albuterol) or per 0.5 mg (Levalbuterol J1751 Injection, Iron Dextran 16.5 , 50 mg J1752 Injection, Iron Dextran 267, 50 mg Effective as of April 1, 2008, the following...
Subscribe or sign in to view the full article.
Article Overview
This premium article provides a Medicare-focused update on HCPCS code changes effective April 1, 2008. It is aimed at coders, billing staff, and reimbursement professionals who need to track which HCPCS drug and inhalation therapy codes were no longer payable, which codes became payable, and which codes were reported as replacements under CMS guidance. The article also points readers to the CMS transmittal associated with the change.
Why This Topic Matters
Medicare HCPCS updates can affect claim submission, payment status, and code maintenance workflows. This article helps readers identify the scope of the April 1, 2008 changes so they can review affected billing processes and reference the related CMS communication.
Article Sections
-
Effective as of April 1, 2008, the following HCPCS codes are no longer payable to Medicare
This section identifies HCPCS drug and inhalation therapy codes that were reported as no longer payable under Medicare as of the stated effective date.
-
Effective as of April 1, 2008, the following HCPCS codes are payable to Medicare
This section lists HCPCS codes that became payable to Medicare as of the stated effective date, covering several related drug and inhalation therapy entries.
-
Replacement note and additional information
This section notes the replacement relationship among selected HCPCS codes and references the CMS transmittal for further information.
What You Will Learn
- Which HCPCS codes were reported as no longer payable to Medicare as of the effective date.
- Which HCPCS codes were reported as payable to Medicare as of the effective date.
- Which older HCPCS codes were noted as being replaced by newer codes.
- How the article frames the update in relation to CMS guidance and Medicare billing.
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Practice managers
- Hospital outpatient coding teams
- Pharmacy billing staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com